Community/Retail

A generic equivalent to Bristol-Myers Squibb's entecavir (Baraclude) hepatitis B treatment has been approved by the FDA.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about information pharmacists should give patients on high-dose basal insulin.

In the recent past, bipolar disorder has been classified as the most costly mental illness.

Bartell Drugs has announced that Frank Segrave, President and CEO of Silvergate Pharmaceuticals and former Vice President of Pharmacy at Walmart, has joined the Bartell Drugs board of directors.

Community pharmacists have the opportunity to identify patients at risk for opioid overdose.

Reasor's has installed automated defibrillators in every store.

Company officials have announced that Food City will once again provide the flu vaccine this immunization season.

Recognition as a health care provider continues to be elusive for pharmacists.

PCSK9 inhibitors offer a new treatment option for patients with inherited conditions that cause high LDL cholesterol.

The Drug Enforcement Administration (DEA) recently made an appearance at a state pharmacy board meeting to appease pharmacists' fears of a crackdown on pharmacies.

As pharmacy students head back to school, an American Association of Colleges of Pharmacy (AACP) infographic offers an informative look at the state of pharmacy education.

Pharmacy technicians should know the following new drugs and expanded indications approved by the FDA in August 2015.

Rico Powell, CPhT, shares his thoughts on the pharmacy technician's growing role in ensuring patient safety and improving health care outcomes.

The FDA has proposed adding a 4-letter suffix to the names of biosimilars to distinguish them from their biologic counterparts.

Multidose medication dispensing at discharge (MMDD) involves supplying products that have been partially used during hospitalization to ensure continuity of care.

The 340B Program "mega-guidance" just released by the Health Resources and Services Administration (HRSA) clarifies how patients can receive deeply discounted drugs.

Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, talks about the benefits and risks of aggressive glycemic controls.

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes may cause severe and disabling joint pain, the FDA has warned.

Adding Afrezza insulin inhalation powder to oral diabetes medications significantly reduces HbA1C in adults with poorly controlled type 2 diabetes.

Many people want to become pharmacy owners, but who is best suited for it?

The pharmacist of tomorrow will be unrecognizable.

Bruce Berger, PhD, president of Berger Consulting LLC, discusses the major differences between motivational interviewing and traditional patient counseling techniques with respect to medication adherence.

Rupal Mansukhani, PharmD, clinical assistant professor at the Ernest Mario School of Pharmacy at Rutgers, talks about the utility of high-dosage flu vaccine in the 65 and older population.

More than half of atrial fibrillation patients discontinue or interrupt warfarin therapy within 1 year of starting treatment.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses the major benefits of introducing new technology to community pharmacy.

Amgen is seeking FDA approval for etelcalcetide, the first calcimimetic agent administered intravenously after dialysis to treat secondary hyperparathyroidism in patients with chronic kidney disease.